Literature DB >> 35444725

The role of continuous glucose monitoring in pregnancy.

Adrian Li1, Anna Brackenridge2.   

Abstract

The risks associated with diabetes in pregnancy include congenital anomalies, stillbirth and miscarriage, and correlate with glycaemia. The optimisation of diabetes during pregnancy is therefore both challenging and essential. Technology has revolutionised how clinicians and patients manage diabetes. This review article focuses on the role of continuous glucose monitoring (CGM) in pregnancy, assessing the evidence available and providing an update on current guidance.
© The Author(s) 2021.

Entities:  

Keywords:  pregnancy; Continuous subcutaneous insulin infusion; continuous glucose monitoring; diabetes mellitus; flash glucose monitoring; insulin pump; macrosomia

Year:  2021        PMID： 35444725      PMCID： PMC9014555          DOI： 10.1177/1753495X211014716

Source DB:  PubMed          Journal:  Obstet Med        ISSN： 1753-495X


  28 in total

1.  The role of continuous glucose monitoring in gestational diabetes mellitus.

Authors:  L Jovanovic
Journal:  Diabetes Technol Ther       Date:  2000       Impact factor: 6.118

2.  Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.

Authors:  Goran Petrovski; Cedomir Dimitrovski; Milco Bogoev; Tatjana Milenkovic; Irfan Ahmeti; Iskra Bitovska
Journal:  Diabetes Technol Ther       Date:  2011-07-13       Impact factor: 6.118

3.  Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus.

Authors:  Graham R Law; Alia Alnaji; Lina Alrefaii; Del Endersby; Sarah J Cartland; Stephen G Gilbey; Paul E Jennings; Helen R Murphy; Eleanor M Scott
Journal:  Diabetes Care       Date:  2019-02-14       Impact factor: 19.112

4.  Continuous glucose monitoring for treatment adjustment in diabetic pregnancies--a pilot study.

Authors:  Y Yogev; A Ben-Haroush; R Chen; B Kaplan; M Phillip; M Hod
Journal:  Diabet Med       Date:  2003-07       Impact factor: 4.359

5.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors:  William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  N Engl J Med       Date:  2008-09-08       Impact factor: 91.245

6.  Real-time continuous glucose monitoring during labour and delivery in women with Type 1 diabetes - observations from a randomized controlled trial.

Authors:  S Cordua; A L Secher; L Ringholm; P Damm; E R Mathiesen
Journal:  Diabet Med       Date:  2013-07-26       Impact factor: 4.359

7.  Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes.

Authors:  Tadej Battelino; Moshe Phillip; Natasa Bratina; Revital Nimri; Per Oskarsson; Jan Bolinder
Journal:  Diabetes Care       Date:  2011-02-19       Impact factor: 19.112

8.  Experiences of gestational diabetes and gestational diabetes care: a focus group and interview study.

Authors:  Judith Parsons; Katherine Sparrow; Khalida Ismail; Katharine Hunt; Helen Rogers; Angus Forbes
Journal:  BMC Pregnancy Childbirth       Date:  2018-01-11       Impact factor: 3.007

9.  Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies.

Authors:  Karl Kristensen; Linda E Ögge; Verena Sengpiel; Karin Kjölhede; Annika Dotevall; Anders Elfvin; Filip K Knop; Nana Wiberg; Anastasia Katsarou; Nael Shaat; Lars Kristensen; Kerstin Berntorp
Journal:  Diabetologia       Date:  2019-03-23       Impact factor: 10.122

10.  Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with Type 1 diabetes.

Authors:  H R Murphy; D S Feig; J J Sanchez; S de Portu; A Sale
Journal:  Diabet Med       Date:  2019-07-04       Impact factor: 4.359
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.